SMMT Archived Articles
Summit Therapeutics Inc. (NASDAQ:SMMT): Building a Biopharmaceutical Giant in Oncology
Published on March 12, 2025
Summit Therapeutics Inc. (SMMT): A Pioneering Biopharmaceutical Conqueror in Oncology
Published on November 30, 2024
Summit Therapeutics Inc. (NASDAQ:SMMT): Betting Big on Ivonescimab's Potential in Lung Cancer and Beyond
Published on September 24, 2024